Philipp Lange (he/him) (@philipplange.bsky.social)

Join us! To accelerate our activities in the Canadian Pediatric Cancer Consortium and PROFYLE we have multiple opportunities to study sarcomas, brain tumours, infant leukemias and employ proteomics to identify treatment options - today. Details: langelab.med.ubc.ca/open-positions

@AgustinMIbanez @NatureAging @lulaamour @HernHdezL @NeuroLang_BCBL @CNCUdeSA @UAI_CL @Psicologia_UAI @tcddublin @UCSFmac @AgingBiology @atlanticfellows @GBHI_Fellows @Bilingual_News This sounds intriguing. Apologies, haven’t read yet so likely you have my question answered in the study - how do you measure and account for increased genomic diversity that one intuitively would expect to find in multi linguistic populations?

Living in multilingual societies is associated with slower aging. Out today in @NatureAging, we tested the dose–effect of multilingualism across 27 countries and over 86,000 participants. Congrats to @lulaamour @HernHdezL & coauthors! doi.org/10.1038/s43587… 🧵 (1/4). @BrainlatUAI @ReDLat_Dementia @LACCD9

@_AndrewLeduc Neither. It’s the rate at which a gene is transcribed. It is one of many more factors that influence the abundance of the transcript. But it is commonly used to describe transcript abundance.

What does "Gene Expression" mean and what is your logic?

Thanks for featuring this major breakthrough in advancing personalized precision oncology in kids beyond genome sequencing to gain additional insight through proteomics and rapid testing of treatment options in personalized xenografts. A great team from all across Canada 🇨🇦!

👋 Calling the Vancouver cancer research community! Join us on the evening of April 2 at the Robert H. Alumni Centre @UBC for our community event. This year’s theme is “Precision Oncology: Bridging Research & Community”. Register now: eventbrite.ca/e/precision-on…

Do you like proteomics? Do you like plants? Join us next Jan 29th to hear from Dr. Uhrig's and Dr. Grubb's research during our first seminar of 2025. Register at: cnpn.ca/seminar/ We are looking forward to seeing you there!

@MDC_Berlin @dfg_public @apombo1 @BIMSB_MDC @helmholtz_de @helmholtz_en @HumboldtUni Congratulations Ana!

Congratulations, Ana Pombo! The #mdcBerlin scientist is awarded Germany's most important science prize: the Gottfried Wilhelm Leibniz Prize by the German Research Foundation (@dfg_public). More about @apombo1 and her work: mdc-berlin.de/news/news/ana-… @BIMSB_MDC @helmholtz_de

WAIT A SECOND! US-HUPO is offering a Rising Star Travel Award for CNPN members! This person should be attending the next Annual US HUPO Conference in Philadelphia, PA, next February 22-26, 2025. Deadline to apply: January 3rd 2025. More details at: cnpn.ca/us-hupo-travel…

Childhood cancers respond differently to treatments compared to adult cancers. With fewer options available, Dr. James Lim is developing a new way of predicting which drugs would be most effective by using chicken eggs as a host model. More: bcchr.info/4fWqDRl #BCCHR2024

Congratulations to Dr Marie Brunet for her CNPN New Investigator Award!🥇 Thanks as well to our sponsor @thermofisher for supporting this award.

Yesterday was a night of gala and awards. From rising stars, travel to life awards. One common denominator: proteomics! We are looking forward to seeing the evolution of their careers!

CNPN 2024 - Morning sessions of Day 3 were excellent as expected! We heard spatial, single cell and targeted proteomics among other novel topics and applications!

Come and enjoy our first poster session during #CNPN2024 !

Our Annual General Meeting is happening now by President @JGMProteomics . We are also highlighting the fantastic work of our organizers, board and sponsors. @thermofisher

First session of #CNPN2024 was a real success! Amazing research going from single cell proteomics to protein-protein interactions!

CNPN 2024 - Trainee day has started! Ice breaker speaker is Mayara Silva talking about her PhD project investigating protein-protein interactions in the human fungal pathogen Cryptococcus neoformans!

CNPN 2024 has officially started! We are looking forward to see all the amazing researchers sharing their work! Stay tuned for more news!

@DocDellaire @majuarcaa I am not saying that you should not disclose. Of course you have to disclose if disclosure is required or you are lying. I am questioning why the use of a ghostwriter/genAI suddenly needs to be disclosed when it is accessible to all but nobody cared when only few could afford it

@Lange_Lab @majuarcaa You are aghast that you somehow plagiarized, you deny plagiarism but your only defense is to confirm that you did indeed use ChatGPT and did not disclose this to CIHR. CIHR pulls your grant as you lied. So basically use gen AI at your own risk if you don't disclose #FAFO 2/2

@DocDellaire @majuarcaa GenAI is not different from a ghostwriter that is not attributed and does or does not plagiarize. It is the responsibility of the applicant to confirm the validity of the submitted words regardless who or what wrote them. Nothing new here.

@majuarcaa I think the guidelines are important as using LLMs trained on copyright materials (litigation and negotiations are on-going with New York Times and Getty Images) can result in copyright infringement and plagiarism that may not fall under "fair use" as it can't be attributed. 1/2

@majuarcaa I think it makes sense to require this (and grammarly would fall under this) but mostly for entirely different reasons. We need to learn how to use it well - and only if we know how others use it can we as a community learn what works and what does not.